Alemtuzumab in combination with high-dose methylprednisolone is a logical, feasible and highly active therapeutic regimen in chronic lymphocytic leukaemia patients with p53 defects

被引：70

作者：

Pettitt, A. R. ^{[1
]}

Matutes, E.

Oscier, D.

机构：

[1] Royal Liverpool Univ Hosp, Dept Haematol, Liverpool, Merseyside, England

[2] Inst Canc Res, Sect Haematooncol, Sutton, Surrey, England

[3] Royal Bournemouth Hosp, Dept Haematol, Bournemouth, Dorset, England

来源：

LEUKEMIA | 2006年 / 20卷 / 08期

关键词：

D O I：

10.1038/sj.leu.2404265

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1441 / 1445

页数：6

共 8 条

[1] p53 expression in B-cell chronic lymphocytic leukemia: A marker of disease progression and poor prognosis [J].

Cordone, I ;

Masi, S ;

Mauro, FR ;

Soddu, S ;

Morsilli, O ;

Valentini, T ;

Vegna, ML ;

Guglielmi, C ;

Mancini, F ;

Giuliacci, S ;

Sacchi, A ;

Mandelli, F ;

Foa, R .

BLOOD, 1998, 91 (11) :4342-4349

[2] Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia [J].

Eichhorst, BF ;

Busch, R ;

Hopfinger, G ;

Pasold, R ;

Hensel, M ;

Steinbrecher, C ;

Siehl, S ;

Jäger, U ;

Bergmann, M ;

Stilgenbauer, S ;

Schweighofer, C ;

Wendtner, CM ;

Döhner, H ;

Brittinger, G ;

Emmerich, B ;

Hallek, M .

BLOOD, 2006, 107 (03) :885-891

[3] P53-DEPENDENT APOPTOSIS MODULATES THE CYTOTOXICITY OF ANTICANCER AGENTS [J].

LOWE, SW ;

RULEY, HE ;

JACKS, T ;

HOUSMAN, DE .

CELL, 1993, 74 (06) :957-967

[4] Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions [J].

Lozanski, G ;

Heerema, NA ;

Flinn, IW ;

Smith, L ;

Harbison, J ;

Webb, J ;

Moran, M ;

Lucas, M ;

Lin, T ;

Hackbarth, ML ;

Proffitt, JH ;

Lucas, D ;

Grever, MR ;

Byrd, JC .

BLOOD, 2004, 103 (09) :3278-3281

[5]

Osuji NC, 2005, HAEMATOLOGICA, V90, P1435

[6] Campath-1H-induced complete remission of chronic lymphocytic leukemia despite p53 gene mutation and resistance to chemotherapy [J].

Stilgenbauer, S ;

Döhner, H .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :452-453

[7] High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities [J].

Thornton, PD ;

Matutes, E ;

Bosanquet, AG ;

Lakhani, AK ;

Grech, H ;

Ropner, JE ;

Joshi, R ;

Mackie, PH ;

Douglas, IDC ;

Bowcock, SJ ;

Catovsky, D .

ANNALS OF HEMATOLOGY, 2003, 82 (12) :759-765

[8] Surfing the p53 network [J].

Vogelstein, B ;

Lane, D ;

Levine, AJ .

NATURE, 2000, 408 (6810) :307-310

← 1 →